Fibronectin (FN) mediates a wide variety of cellular interactions with the extracellular matrix (ECM) and plays important roles in cell adhesion, migration, growth and differentiation (Mosher, 1989; Carsons, 1989; Hynes, 1990; Yamada and Clark, 1996) . FN is widely expressed by multiple cell types and is critically important in vertebrate development, as demonstrated by the early embryonic lethality of mice with targeted inactivation of the FN gene (George et al., 1993) . Although FN has been studied for more than two decades, this remarkably complex molecule is still the subject of exciting discoveries, such as finding new integrin-and heparin-binding sites (Mostafavi-Pour et al., 2001; Liao et al., 2002) or even a new form of the molecule (Zhao et al., 2001 ) that mediates a particular viral infection (Liu and Collodi, 2002 (Patel et al., 1987) .
Although FN molecules are the product of a single gene, the resulting protein can exist in multiple forms that arise from alternative splicing of a single premRNA that can generate as many as 20 variants in human FN (for reviews, see ffrench-Constant, 1995; Kosmehl et al., 1996) Extensive analyses have narrowed down the regions involved in cell adhesion along the lengthy FN molecule to several minimal integrin-recognition sequences (middle panel, single amino-acid sequences in red). The best known of these -RGD -is located in FN repeat III10. The recognition of this simple tripeptide sequence is complex and depends on flanking residues, its threedimensional presentation and individual features of the integrin-binding pockets. For example, a second site in FN repeat III 9 (the 'synergy site' PHSRN, green) promotes specific α5β1 integrin binding to FN, apparently via interactions with the α5 subunit. However, binding of the FN receptor α 5β1 to FN is not restricted only to repeats III9 and III10. It can also interact with an N-terminal fragment containing repeats I1-9 and II1,2, which also promotes α5β1-integrin-mediated cell adhesion. Interestingly, interaction with this N-terminal region can trigger integrin-mediated intracellular signals that are distinct from those generated in response to ligation with the RGD sequence.
A second set of FN sequences, which are bound by the α 4β1 integrin, has also received considerable attention. Two cell-recognition sequences (LDV and REDV) were originally identified in the alternatively spliced V region. Both of them are recognized by α 4β1 and α4β7. Additional sites recognized by the α4β1 integrin -IDAPS and KLDAPT -are also present in repeats III 14 and III5, respectively (the latter also binds to the α 4 β 7 integrin). Recently, binding of α 4β1 as well as α9β1 to an EDGIHEL sequence located within the alternatively spliced EDA segment has been reported, suggesting a possible adhesive function for the increased EDA-containing FN species observed during wound healing (Liao et al., 2002) .
Elucidation of the sites of integrin binding as well as other functionally important domains within the FN molecule was greatly facilitated by the early discovery that all FNs are cleaved only in specific regions when subjected to limited proteolytic digestion (reviewed by Mosher, 1989; Hynes, 1990) . Even a protease capable of cleaving proteins at many sites (such as pronase) will initially cleave FN, and it will only do this at highly specific, probably non-folded, unprotected locations. A simplified scheme of the major proteolytic cleavage sites is shown in the middle panel (see Major proteolytic digestion sites). The binding activities of FN are often preserved after such proteolysis and can be identified within particular fragments. FN has a remarkably wide variety of functional activities besides binding to cell surfaces through integrins. It binds to a number of biologically important molecules that include heparin, collagen/gelatin, and fibrin. These interactions are mediated by several distinct structural and functional domains, which have been defined by proteolytic fragmentation or recombinant DNA analyses (see Mosher, 1989; Hynes, 1990; Yamada and Clark, 1996 ; and the website Journal of Cell Science 115 (20) 1 In chicken, the whole 120 amino acid residues of the V region can be included or a 44 amino acid segment from the 5′ end can be excluded (creating V76), but the whole V region is never missing. A similar mechanism leads to exclusion of a 25 amino acid fragment in rat, generating V95 that can be detected together with V0 and V120 forms. Splicing of the V region is even more complicated in human where segments from both 5′ (25aa) and 3′ (31aa) ends can be omitted independently (creating V95 and V89 correspondingly) or together (V64) producing five different V regions.
http://www.gwumc.edu/biochem/ingha m/fnpage.htm).
FN contains two major heparin-binding domains that interact with heparan sulfate proteoglycans (right panel, Ligand interaction sites). The strongest heparin-binding site is located in the Cterminal part (Heparin II) and a weaker binding domain is situated at the Nterminal end of the protein (Heparin I). The high-affinity heparin II domain can also bind to a widely distributed glycosaminoglycan, chondroitin sulfate, whereas the weaker heparin-binding domain contains a Staphylococusaureus-binding site that mediates FN interactions with bacteria. Recently, a novel glycosaminoglycan-binding site has been identified within the V region of FN (Mostafavi-Pour et al., 2001 ) (marked as 'Heparin' at the V domain). In at least some cell types, the heparinbinding domains of FN potentiate cell adhesion.
The collagen-binding domain includes repeats I6-9 and II1,2, and it binds far more effectively to denatured collagen (gelatin) than to native collagen. Thus, FN interactions with collagens in general may be due to its binding to unfolded regions of the collagen triple helix. It has been suggested that the physiological function of the collagen/gelatin-binding domain is related more to binding and clearance of denatured collagenous materials from blood and tissue than to mediating cell adhesion to collagen. Interestingly, however, a recent analysis of the physiological state of collagen indicates that the triple helix is likely to unfold locally at body temperature (Leikina et al., 2002) , which suggests that this FN domain could be involved in interactions with native collagen in vivo.
FN also contains two major fibrinbinding sites (Fibrin I and Fibrin II) . The major site is in the N-terminal domain and is formed by type I repeats 4 and 5. The interaction of FN with fibrin is thought to be important for cell adhesion or cell migration into fibrin clots. In both cases, cross-linking between FN and fibrin mediated by factor XIII transglutaminase is proposed to mediate the effect (the cross-linking site on the FN molecule is marked by factor XIIIa and an arrow). The interaction of FN with fibrin may also be involved in macrophage clearance of fibrin from circulation after trauma or in inflammation.
FNs are glycoproteins that contain 4-9% carbohydrate, depending on the cell source. Glycosylation sites that are either N-linked (red stars) or O-linked (green star) reside predominantly within type III repeats and the collagen-binding domain. The physiological role of the carbohydrates is not certain, although they appear to stabilize FN against hydrolysis and modulate its affinity to some substrates.
Although the plasma FN that circulates in blood is in a closed, reportedly nonactive form, most of the FN activities in the body have been ascribed to the insoluble form of FN that exists as part of the extracellular matrix (see the immunofluorescence image obtained with anti-FN antibodies at the bottom of the middle panel labeled Fibronectinbased matrix). The creation and deposition of insoluble FN fibrils into the ECM is a tightly regulated, cellmediated process termed FN fibrillogenesis or FN matrix assembly (for a review, see Geiger et al., 2001) . A critical step in this process is selfassociation of FN into aggregates and fibrils, which is directed by multiple binding sites that have been identified along the molecule (right panel, Sites involved in fibronectin fibrillogenesis). Some of these self-interaction sites are exposed and available for binding (marked in yellow), while others are cryptic (marked in light brown) and become accessible only after conformational changes, for example, by cell-driven mechanical stretching of the FN molecule.
FN is one of the largest multi-domain proteins for which domain organization, molecular interactions, and key functions have been established in great detail. Exploration of the cell-typespecific splicing variants, glycosylation patterns and their relationship to health and disease will be further challenges in the study of this fascinating molecule.
